Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q2 2025 · 10-Q
Revenue$297.03M$297.03M+9.0% vs Q2 2024 Net Income$34.89M$34.89M+27.0% vs Q2 2024 EPS Diluted$0.22$0.22+29.4% vs Q2 2024 Gross Profit$193,886,000+9.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$84,346,000+1.5% Free Cash Flowderived$77,525,000+13.6% Margins · derivedGross margin65.3%+0.5 pt vs Q2 2024
Operating margin16.0%+2.0 pt vs Q2 2024
Net margin11.7%+1.7 pt vs Q2 2024
ended Dec 31, 2024 · filed Feb 6, 2025 · 37 d after period end